FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2324016220> ?p ?o ?g. }

• W2324016220 endingPage "2160" @default.
• W2324016220 startingPage "2148" @default.
• W2324016220 abstract "Targeted immune tolerance is a coveted therapy for the treatment of a variety of autoimmune diseases, as current treatment options often involve nonspecific immunosuppression. Intravenous (iv) infusion of apoptotic syngeneic splenocytes linked with peptide or protein autoantigens using ethylene carbodiimide (ECDI) has been demonstrated to be an effective method for inducing peripheral, antigen-specific tolerance for treatment of autoimmune disease. Here, we show the ability of biodegradable poly(lactic-co-glycolic acid) (PLG) nanoparticles to function as a safe, cost-effective, and highly efficient alternative to cellular carriers for the induction of antigen-specific T cell tolerance. We describe the formulation of tolerogenic PLG particles and demonstrate that administration of myelin antigen-coupled particles both prevented and treated relapsing-remitting experimental autoimmune encephalomyelitis (R-EAE), a CD4 T cell-mediated mouse model of multiple sclerosis (MS). PLG particles made on-site with surfactant modifications surpass the efficacy of commercially available particles in their ability to couple peptide and to prevent disease induction. Most importantly, myelin antigen-coupled PLG nanoparticles are able to significantly ameliorate ongoing disease and subsequent relapses when administered at onset or at peak of acute disease, and minimize epitope spreading when administered during disease remission. Therapeutic treatment results in significantly reduced CNS infiltration of encephalitogenic Th1 (IFN-γ) and Th17 (IL-17a) cells as well as inflammatory monocytes/macrophages. Together, these data describe a platform for antigen display that is safe, low-cost, and highly effective at inducing antigen-specific T cell tolerance. The development of such a platform carries broad implications for the treatment of a variety of immune-mediated diseases." @default.
• W2324016220 created "2016-06-24" @default.
• W2324016220 creator A5016427677 @default.
• W2324016220 creator A5033876610 @default.
• W2324016220 creator A5051108903 @default.
• W2324016220 creator A5057116038 @default.
• W2324016220 creator A5062718468 @default.
• W2324016220 creator A5073323104 @default.
• W2324016220 creator A5077468407 @default.
• W2324016220 date "2014-02-27" @default.
• W2324016220 modified "2023-10-18" @default.
• W2324016220 title "A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease" @default.
• W2324016220 cites W1514064771 @default.
• W2324016220 cites W1577354978 @default.
• W2324016220 cites W1603311433 @default.
• W2324016220 cites W1610027395 @default.
• W2324016220 cites W1652237838 @default.
• W2324016220 cites W1787818619 @default.
• W2324016220 cites W1833759296 @default.
• W2324016220 cites W1896583420 @default.
• W2324016220 cites W1914175997 @default.
• W2324016220 cites W1965647100 @default.
• W2324016220 cites W1967904326 @default.
• W2324016220 cites W1969380527 @default.
• W2324016220 cites W1970547229 @default.
• W2324016220 cites W1973354670 @default.
• W2324016220 cites W1978684572 @default.
• W2324016220 cites W1980213997 @default.
• W2324016220 cites W1981688486 @default.
• W2324016220 cites W1983980454 @default.
• W2324016220 cites W1989726308 @default.
• W2324016220 cites W1992215904 @default.
• W2324016220 cites W2015497529 @default.
• W2324016220 cites W2018896468 @default.
• W2324016220 cites W2035757734 @default.
• W2324016220 cites W2040838085 @default.
• W2324016220 cites W2041266914 @default.
• W2324016220 cites W2043683714 @default.
• W2324016220 cites W2056300078 @default.
• W2324016220 cites W2057043713 @default.
• W2324016220 cites W2061212581 @default.
• W2324016220 cites W2063715085 @default.
• W2324016220 cites W2066352983 @default.
• W2324016220 cites W2074463323 @default.
• W2324016220 cites W2086547450 @default.
• W2324016220 cites W2090030504 @default.
• W2324016220 cites W2091601326 @default.
• W2324016220 cites W2097222424 @default.
• W2324016220 cites W2105838733 @default.
• W2324016220 cites W2106467284 @default.
• W2324016220 cites W2109577352 @default.
• W2324016220 cites W2112239380 @default.
• W2324016220 cites W2112818950 @default.
• W2324016220 cites W2117002902 @default.
• W2324016220 cites W2125123295 @default.
• W2324016220 cites W2125504851 @default.
• W2324016220 cites W2141664407 @default.
• W2324016220 cites W2156368993 @default.
• W2324016220 cites W2159854678 @default.
• W2324016220 cites W2166712548 @default.
• W2324016220 cites W2169515956 @default.
• W2324016220 cites W2169726349 @default.
• W2324016220 cites W2332169547 @default.
• W2324016220 cites W295908243 @default.
• W2324016220 doi "https://doi.org/10.1021/nn405033r" @default.
• W2324016220 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3990004" @default.
• W2324016220 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24559284" @default.
• W2324016220 hasPublicationYear "2014" @default.
• W2324016220 type Work @default.
• W2324016220 sameAs 2324016220 @default.
• W2324016220 citedByCount "241" @default.
• W2324016220 countsByYear W23240162202014 @default.
• W2324016220 countsByYear W23240162202015 @default.
• W2324016220 countsByYear W23240162202016 @default.
• W2324016220 countsByYear W23240162202017 @default.
• W2324016220 countsByYear W23240162202018 @default.
• W2324016220 countsByYear W23240162202019 @default.
• W2324016220 countsByYear W23240162202020 @default.
• W2324016220 countsByYear W23240162202021 @default.
• W2324016220 countsByYear W23240162202022 @default.
• W2324016220 countsByYear W23240162202023 @default.
• W2324016220 crossrefType "journal-article" @default.
• W2324016220 hasAuthorship W2324016220A5016427677 @default.
• W2324016220 hasAuthorship W2324016220A5033876610 @default.
• W2324016220 hasAuthorship W2324016220A5051108903 @default.
• W2324016220 hasAuthorship W2324016220A5057116038 @default.
• W2324016220 hasAuthorship W2324016220A5062718468 @default.
• W2324016220 hasAuthorship W2324016220A5073323104 @default.
• W2324016220 hasAuthorship W2324016220A5077468407 @default.
• W2324016220 hasBestOaLocation W23240162201 @default.
• W2324016220 hasConcept C126322002 @default.
• W2324016220 hasConcept C147483822 @default.
• W2324016220 hasConcept C159654299 @default.
• W2324016220 hasConcept C195616568 @default.
• W2324016220 hasConcept C203014093 @default.
• W2324016220 hasConcept C2776090121 @default.
• W2324016220 hasConcept C2777701055 @default.
• W2324016220 hasConcept C2777702733 @default.

• next